Registered number: 13314375

A2z Microbiology Ltd
Unaudited Financial Statements
for the period ended 31 January 2024

Statement of Financial Position

as at 31 January 2024

  2024
2023
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  -  
 
  3,115  
Current assets  
43,086    
 
79,619    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
( 17,744 )  
 
( 31,403 )  
Net current assets (liabilities)  
  25,342  
 
  48,216  
Total assets less current liabilities  
  25,342  
 
  51,331  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  ( 453 )
 
  -  
Net assets  
  24,889  
 
  51,331  
   
Capital and reserves  
  24,889  
 
  51,331  

xbrli:pure 13314375 2023-05-01 2024-01-31 13314375 2022-05-01 2023-04-30 13314375 2024-01-31 13314375 2023-04-30 13314375 2023-05-01 13314375 uk-frs102:WithinOneYear 2024-01-31 13314375 uk-frs102:AfterOneYear 2024-01-31 13314375 uk-frs102:WithinOneYear 2023-04-30 13314375 uk-frs102:AfterOneYear 2023-04-30 13314375 uk-bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-01-31 13314375 uk-bus:FilletedAccounts 2023-05-01 2024-01-31 13314375 uk-bus:Director1 1 2023-05-01 2024-01-31 13314375 uk-bus:Director2 2 2023-05-01 2024-01-31 13314375 uk-bus:Director1 2023-05-01 2024-01-31 13314375 uk-bus:Director2 2023-05-01 2024-01-31 13314375 uk-bus:Director1 1 2023-05-01 13314375 uk-bus:Director2 2 2023-05-01 13314375 uk-bus:Director1 1 2024-01-31 13314375 uk-bus:Director2 2 2024-01-31 13314375 uk-bus:Micro-entities 2023-05-01 2024-01-31 13314375 uk-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-01-31 iso4217:GBP 13314375 countries:EnglandWales 2023-05-01 2024-01-31 13314375 uk-bus:RegisteredOffice 2023-05-01 2024-01-31

Footnotes to the Statement of Financial Position

Lina Ximena Celis Bautista Tamryn Jo Hassell

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 2.

3. Directors’ benefits: advances, credit and guarantees

Lina Ximena Celis Bautista

Included in debtors is an amount payable to the company by one of its directors. The amount is an advance of £16,800 made to Lina Ximena Celis Bautista, a director of the company, on 28/05/2023.

During the accounting period the maximum amount payable by Lina Ximena Celis Bautista was £34,204

The following conditions are attached to the amount payable by Lina Ximena Celis Bautista:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 01/05/2023 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 31/01/2024
£ £ £ £ £ £ £
0   ( 34,988 )
( 34,988 )
18,188
18,188  
0 0 0 ( 16,800 )

Tamryn Jo Hassell

Included in debtors is an amount payable to the company by one of its directors. The amount is an advance of £26,187 made to Tamryn Jo Hassell, a director of the company, on 01/05/2023.

During the accounting period the maximum amount payable by Tamryn Jo Hassell was £32,437

The following conditions are attached to the amount payable by Tamryn Jo Hassell:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 01/05/2023 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 31/01/2024
£ £ £ £ £ £ £
0   ( 32,589 )
( 32,589 )
6,402
6,402  
0 0 0 ( 26,187 )

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

5. Going Concern

The company ceased to trade during the period and the accounts have been prepared on a break-up basis.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the period ending 31/01/2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 13314375

c) The company is a private company and is limited by shares

d) The companies registered office address is 3rd Floor 86 - 90 Paul Street, London, EC2A 4NE, England

e) Company ceased to trade on 31/01/2024



Approved by the board of directors and signed on behalf of the board,

A2z Microbiology Ltd
Director Lina Ximena Celis Bautista
Date of approval: 29/08/2024
The company was trading for the entire period 2023-05-01 2024-01-31 2024-01-31 Consultancy services 2024-08-29 2024-08-29